NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . October 26th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Alzheimer Disease - EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patient

arGentis Pharmaceuticals, LLC - arGentis Expands Scientific Advisory Board

Diabetes - Positive Findings from Excellarate(TM) Phase 1/2 Clinical Study Published in Journal of Wound Repair and Regeneration

Emisphere Technologies, Inc. - Study Results Suggest Oral Salmon Calcitonin Using Eligen(R) Drug Delivery Technology May Reduce Cartilage and Bone Degradation in Osteoarthritis

Schering-Plough - Schering-Plough Highlights Boceprevir, Narlaprevir SCH 900518 and PEGINTRON Data at the American Association for the Study of Liver Diseases AASLD 2009 Annual Meeting

Amyotrophic Lateral Sclerosis - Reports outline amyotrophic lateral sclerosis study results from Columbia University

Arthritis - Research on arthritis detailed by scientists at Osaka University

Cancer Gene Therapy - Research from Wayne State University in the area of cancer gene therapy published

Colon Cancer - Researchers at Medical University of South Carolina target colon cancer

Crohn Disease - Research from University of Florida provides new data about Crohn disease

Enzyme Research - New enzyme research study findings recently were reported by researchers at University of Kentucky

Enzyme Research - Research from AstraZeneca broadens understanding of enzyme research

Falciparum Malaria - Researchers at GlaxoSmithKline release new data on falciparum malaria

Heart Attack - Research by I. Ahrens and colleagues in heart attack provides new insights

Mantle Cell Lymphoma - Studies by L.E. Garbo and co-authors describe new findings in mantle cell lymphoma

Monoclonal Antibodies - Study results from J.F. Colombel and colleagues update understanding of monoclonal antibodies

Oropharyngeal Cancer - Study results from University of Maryland provide new insights into oropharyngeal cancer

Prostate Cancer - Studies in the area of prostate cancer reported from S. Marzi and co-researchers

Clinical Trial Research - Study findings from University of Exeter broaden understanding of clinical trial research

Non-Small Cell Lung Cancer Therapy - Researchers from University of Navarra, Department of Oncology report recent findings in non-small cell lung cancer therapy

Advaxis, Inc. - Advaxis Added to Stonegate's Equity Research Universe

Alkermes, Inc. - Alkermes Announces Positive Results From Two Clinical Trials of ALKS 33

Argos Therapeutics - Argos Therapeutics to Present Positive Immune Response and Viral Load Data for Arcelis(TM) HIV Program at the AIDS Vaccine 2009 Conference

Business Wire Global Event Services - BioPartnering Europe 2009 Presenter Profile

Clinical Trial Research - Resverlogix Updates Shareholders on Accelerated Clinical Trial Plan

Clinical Trial Research - Soligenix Announces Initiation of its Confirmatory Phase 3 Clinical Trial of orBec(R) in Acute GI GVHD

Constipation - Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix

Depomed, Inc. - Depomed Reports Results From Two Phase 3 Clinical Trials Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes

Diabetes - Metabolex Announces Positive Phase 1 Clinical Trial Results of MBX-2982

Endocyte Inc. - Endocyte Officials Announce Close of $26 Million Equity Financing

Genetic Disorders - CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.

HIV/AIDS - NeuroAIDS is Target of Federal Grant to Children's Hospital

KaloBios Pharmaceuticals, Inc. - KaloBios' KB001 Antibody Shows Encouraging Safety and Activity in New Approach to Fighting Pseudomonas Infection in Cystic Fibrosis Patients

Lysosomal Storage Disease - ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease

NanoBio Corporation - NanoBio and the University of Michigan to Receive $9.3M from the NIH for Nanoemulsion-Based Vaccine Development

NexMed, Inc. - NexMed Provides Update on Anti-Fungal Product

Obesity - Arena Pharmaceuticals' Lorcaserin to be Featured in Multiple Presentations at Obesity 2009

Obesity and Diabetes - Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH)

OPKO Health, Inc. - OPKO Health Acquires Lead NK-1 Compounds from Schering-Plough Corporation

Pancreatic Cancer - Advanced U.S. Clinical Trial Confirms Single-Agent Efficacy of Rexin-G in Metastatic Pancreas Cancer: All Endpoints Achieved

Pharmaceuticals - Celator(R) Pharmaceuticals Completes Enrollment Early in Phase 2 Study of CPX-351 in Newly Diagnosed AML

Pharmaceuticals - Transdel Pharmaceuticals Appoints Dr. Joachim P.H. Schupp as Chief Medical Officer

RNA Research - Cequent to Provide Details at BIOCOM About Planned Launch of its Clinical Program - 3 p.m., Tuesday, October 27

Stem Cell Research - Stemedica Completes Meeting With the FDA

Type 2 Diabetes - Metabolic Solutions Development Company To Test Potential Treatment for Alzheimer's

ZIOPHARM Oncology, Inc. - ZIOPHARM Announces Positive Palifosfamide Sarcoma Randomized Phase II Interim Data: Trial Enrollment Stopped Early



Return to Top of Page

-----------------------
PR Login